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Abstract: 
Background: Antimicrobial resistance (AMR) is a major clinical challenge globally. It is mainly a consequence of 
inappropriate prescribing and use of antibiotics. Antimicrobial stewardship (AMS) ensures that antibiotics are 
prescribed and used appropriately. This study assessed AMS practice in selected Nigerian hospitals.                
Methodology: This was a cross sectional survey of 20 Federal, State and Private tertiary hospitals randomly selected 
from the six geopolitical zones of Nigeria. Using an adapted WHO tool on AMS, data were collected from each hospital 
as regard the existence of AMS committee, Accountability and Responsibility, AMS actions, Education and Training, 
Monitoring and Evaluation, Infection Prevention and Control (IPC) practice, facilities to support AMS, and challenges 
to AMS implementation. Gaps and challenges to the implementation of the AMS among the hospitals were identified.  
Results: Only 6 (30%) of the 20 hospitals had AMS committees while 2 (10%) had any evidence of leadership 
commitment to AMS. All the hospitals had laboratory facilities to support culture and sensitivity testing. There were 
no regular AMS-related education or training, monitoring, evaluation or reporting activities in the hospitals, except in 
7 (25%) that had participated in the global point prevalence survey (Global-PPS) of antimicrobial use and resistance 
being hosted by the University of Antwerp, Belgium. Challenges impeding AMS activities included lack of human and 
financial resources, prescribers’ opposition, lack of awareness and absence of AMS committees. Most of the gaps and 
challenges bordered on seeming lack of knowledge and inadequate communication among prescribers and other 
stakeholders.                                               
Conclusion: There is need for intense education and training activities for prescribers and other stakeholders, 
including but not limited to hospital administrators.  
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Abstrait: 
Contexte: La résistance aux antimicrobiens (RAM) est un défi clinique majeur à l'échelle mondiale. C'est 
principalement une conséquence d'une prescription et d'une utilisation inappropriées d'antibiotiques. La gestion des 
antimicrobiens (AMS) garantit que les antibiotiques sont prescrits et utilisés de manière appropriée. Cette étude a 
évalué la pratique de l'AMS dans certains hôpitaux Nigérians.                    
Méthodologie: Il s'agissait d'une enquête transversale de 20 hôpitaux tertiaires fédéraux, d'État et privés 
sélectionnés au hasard dans les six zones géopolitiques du Nigéria. À l'aide d'un outil OMS adapté sur l'AMS, des 
données ont été collectées auprès de chaque hôpital en ce qui concerne l'existence d'un comité AMS, la responsabilité 
et la responsabilité, les actions AMS, l'éducation et la formation, le suivi et l'évaluation, la pratique de prévention et 
de contrôle des infections (IPC), les installations pour soutenir l'AMS. et les défis de la mise en œuvre de l'AMS. Les 
lacunes et les défis liés à la mise en œuvre de l'AMS parmi les hôpitaux ont été identifiés.                 
Résultats: Seuls 6 (30%) des 20 hôpitaux avaient des comités AMS tandis que 2 (10%) avaient des preuves 
d'engagement du leadership envers l'AMS. Tous les hôpitaux disposaient d'installations de laboratoire pour soutenir 
la culture et les tests de sensibilité. Il n'y avait pas d'activités régulières d'éducation ou de formation, de suivi, 
d'évaluation ou de rapportage liées à la MGS dans les hôpitaux, sauf dans 7 (25%) qui avaient participé à l'enquête 
mondiale sur la prévalence ponctuelle (Global-PPS) de l'utilisation et de la résistance aux antimicrobiens organisée 
par l'Université d'Anvers, Belgique. Les défis entravant les activités de l'AMS comprenaient le manque de ressources 
humaines et financières, l'opposition des prescripteurs, le manque de sensibilisation et l'absence de comités AMS. La 
plupart des lacunes et des défis se limitaient à un manque apparent de connaissances et à une communication 
inadéquate entre les prescripteurs et les autres intervenants.                            
Conclusion: Des activités d'éducation et de formation intensives sont nécessaires pour les prescripteurs et autres 
intervenants, y compris, mais sans s'y limiter, les administrateurs d'hôpitaux. 
Mots clés: enquête, gestion des antimicrobiens, résistance aux antimicrobiens; Nigeria 
Introduction:  
 Antimicrobial resistance (AMR) has 
become a major challenge in clinical practice 
especially in the management of bacterial 
infections. The discovery of penicillin by Fleming 
in 1928 revolutionized medicine and brought 
hope of eradicating infections as exemplified by 
the infamous quote allegedly made by the 
United States Surgeon General Dr. Willian H. 
Stewart about 1967-1969, for which no source 
has been traced till date (1,2). Notwithstanding, 
the quote “it is time to close the books on 
infection and declare the war against pestilence 
won” was often used to underscore the ever-
increasing challenge of antibiotic-resistant and 
emerging infections.    
 The tendency of bacteria to develop 
resistance to antibiotics and its likely negative 
impact was revealed by Fleming in his Nobel 
prize award lecture in 1945 (3). Presently many 
common clinical isolates have developed one 
form of resistance or the other to most of the 
commonly used antibiotics and this has led to 
increased morbidity, mortality, length of hos- 
pital stay and healthcare cost. Between 1996 
and 2018, the prevalence of methicillin resis- 
tance in Staphylococcus aureus rose from below 
10% to above 50% in many countries in Africa, 
including Nigeria (5-8). It is estimated that at 
present, antibiotic resistance kills about 700,000 
yearly worldwide, and that this figure has been 
projected to rise to about 10 million by 2050, 
with attendant economic crises (4).  
 Several studies have identified antibiotic 
selective pressure as the single most important 
driver of resistance in bacteria. The selective 
pressure results from use of antibiotics, particu- 
larly when used inappropriately (9,10,). In a 
study by Hecker et al., (11), it was reported that 
576 (30%) of a total of 1941 antimicrobial days 
of therapy prescribed for 129 patients were 




unnecessary. The most common reasons for the 
unnecessary therapy included longer therapy 
than recommended (33%), non-infectious/non-
bacterial syndrome (32%), colonizing or conta- 
minating organisms (16%) and redundant pre- 
scriptions (10%). Similarly, antibiotic use has 
been found to correlate with antibiotic resistance 
(12-15); the more antibiotics are used, the 
more resistance develops and vice-versa. The 
World Health Organisation (WHO) estimates that 
by 2050, antimicrobial resistance will cost the 
world about $100 trillion per annum if left 
unchecked (16). The WHO has also warned that 
the world is running out of antibiotics, and 
therefore urgent action is required for remedy 
(17).      
 To stem the emergence and rise in AMR 
and reserve drugs for the future, rational 
antibiotic use in humans and animal husbandry 
was recognized as a key strategy (18,19). The 
antimicrobial stewardship (AMS) strategy was 
introduced to ensure that only the right patient 
is given the right antibiotics for the right 
indication in the right dose for the right duration 
using the right route with the goals of reducing 
emergence of resistance, morbidity, mortality, 
length of hospital stay and healthcare cost due 
to infectious diseases (19,20). This strategy is 
in use in many parts of the world, especially in 
the developed countries. In Nigeria, the availa- 
bility of antimicrobial stewardship programmes 
(ASPs) in hospitals is grossly inadequate and 
antimicrobial prescribing patterns are largely 
empirical (21).     
 This cross-sectional survey of Federal, 
State and Private tertiary hospitals in Nigeria 
was therefore designed to identify gaps and 
challenges that have stood against AMS practice 
in the country, the result of which is expected to 
serve as guide for stakeholders in planning for 
and implementing AMS programmes to improve 
the quality of healthcare and safety of patients. 
Materials and method: 
Study setting      
 The study setting is the Nigeria health 
system, which is structured in a tiered hierar- 
chical manner; primary, secondary, and tertiary 
hospitals. These hospitals are under the controls 
of different administrative levels and provide 
varying complexity of services. The tertiary 
hospitals are the most specialized and are often 
under the control of the Federal (mostly) and 
some State Government, as well as few Private 
(Faith-based) organizations. They are often the 
most funded and have specialized manpower to 
provide tertiary level health care, training and 
research. They comprise the university teaching 
hospitals, federal medical centers, and specia- 
lized hospitals such as the neuropsychiatric and 
the orthopaedic hospitals. These hospitals often 
have well equipped laboratory services suppor- 
ting their service provision and research.  
Study design and sampling technique   
 This was a cross sectional survey of 20 
out of 40 Federal, State and Private tertiary 
hospitals in Nigeria offering general acute and 
long-term cares and excluding the specialized 
hospitals. The list of all the Federal, State and 
Private tertiary hospitals was generated, and 3 
hospitals were selected by balloting from each 
of the six geopolitical zones of the country. One 
additional hospital each was selected from two 
geopolitical zones with the highest number of 
tertiary hospitals. Only tertiary hospitals were 
included as they stood any chance of carrying 
out bacterial cultures, antimicrobial suscepti- 
bility and AMS given the resources available to 
them. The selected hospitals were then invited 
to participate in the survey 
Data collection instrument and analysis  
 A semi-structured questionnaire adap- 
ted from the WHO template (22) was e-mailed 
by the principal investigator from the central 
study site to each selected centre through an 
identified focal person who completed the 
questionnaire for the participating centre and 
returned for central collation and analysis. The 
questionnaire had different sections which asse- 
ssed the existence of AMS committee in the 
hospital, Accountability and Responsibility, AMS 
actions, Education and Training, Monitoring and 
Evaluation, Infection Prevention and Control 
(IPC) practice, facilities to support AMS, and 
challenges to AMS implementation.   
 Gaps and challenges facing the different 
hospitals in implementing AMS were identified. 
The responses were summarized and presented 
in frequency tables using Microsoft Excel 2016.  
Results: 
 Of the 20 hospitals that participated in 
the survey, AMS committees were in existence 
in only 6 (30%) hospitals. Two hospitals (10%) 
had written evidence of leadership commitment 
while resource allocation by management and 
AMS policy document existed in only 1 (5%) 
hospital (Table 1).    
 All the AMS committees in the 6 hospi- 
tals comprise multidisciplinary members with 
clearly defined leadership. Terms of reference 
were available in only 2 of the 6 (33.3%) hos- 
pitals, while none has been having regular 
meetings of the committee or providing regular 
reports. Whereas 5 (25%) of the 20 hospitals 




had IPC committees, only 1 (5%) had an AMS-
IPC interface (Table 1).   
 Only 1 (5%) hospital had any form of 
treatment guidelines in place. None had anti- 
biotic approval or restriction policy or audit, and 
none gave regular feedback to prescribers. 
Hospital formulary was available in 4 (20%) 
hospitals. One hospital has had training for 
prescribers and other stakeholders as at the 
time of the survey, but it was not sustained or 
regular. The only form of monitoring and 
evaluation in place was the periodic participation 
in the global point prevalence survey (Global-
PPS) of antimicrobial consumption and resis- 
tance hosted by the University of Antwerp, 
Belgium, by a total of 7 (35%) hospitals. 
Prescription sheets, drug charts and laboratory 
facilities for culture and antibiotic susceptibility 
were available in all the hospitals, while infor- 
mation technology (IT) facilities were available 
in 11 (55%). None of the charts or prescription 
sheets were standardized for AMS activity. 
Antibiotic policy was present in 2 (10%) hospi- 
tals (Table 1).     
 All hospitals identified some challenges 
to AMS implementation, which included lack of 
awareness, non-commitment of management, 
prescribers’ challenge, and lack of human and 
financial resources (Table 2). 
 
 
Table 1: Availability of AMS practices and identified gaps from hospitals in Nigeria 
 
AMS Elements 
Components of the AMS Elements Present/Available 
n = 20 









Existence of AMS Committees 6 (30) 14 (70) 
Written evidence of leadership commitment 3 (15) 17 (85) 
Resource Allocation 1 (5) 19 (95) 
AMS identified as priority 1 (5) 19 (95) 
AMS policy document 1 (5) 19 (95) 
   
Accountability and 
Responsibility 
Multidisciplinary AMS Committee 6 (30) 14 (70) 
AMS Terms of Reference 2 (10) 18 (90) 
Regular Meetings 0 20 (100) 
   
AMS Actions Treatment Guidelines 1 (5) 19 (95) 
Antibiotic Approvals/Restrictions 0 20 (100) 
Antibiotic Audit 0 20 (100) 
Hospital Formulary 4 (20) 16 (80) 
   
Education and Training Training for Prescribers and other AMS stakeholders 1 (5) 19 (95) 
   
Monitoring and 
Evaluation 
Indication, Dose, Duration, Route Monitoring 0 20 (100) 
Surveillance 7 (35) 13 (65) 
   
Reporting and Feedback Regular reports to prescribers and others, and 
Feedbacks 
0 20 (100) 
   
AMS Support Facilities Clinical laboratories for culture and sensitivity 20 (100) 0 
Prescription sheets 20 (100) 0 
Drug charts 20 (100) 0 
Standardized drug chart and prescription sheet 0 20 (100) 
IT Facilities 11 (55) 9 (45) 
   
IPC Activity Antibiotic policy 2 (10) 18 (90) 
IPC Committee 5 (25) 15 (75) 
AMS-IPC Interaction 1 (5) 19 (95) 
 
 




Table 2: Identified challenges impeding AMS practice in Nigerian hospitals 
Challenges No of Hospitals (%) 
Lack of Funding 15 (75) 
Poor awareness of AMS usefulness by staff 12 (60) 
Prescribers’ opposition 11 (55) 
Lack of IT Facilities 9 (45) 
No ASP committee 9 (45) 
Higher priorities 8 (40) 
Lack of Staff 8 (40) 
Lack of Leadership Support 7 (35) 
Administration not aware of programme 6 (30) 
ASP =Antimicrobial Stewardship Programme; IT= Information Technology 
Discussion:  
 This cross-sectional survey was desi- 
gned to identify factors hindering the practice of 
AMS in Nigeria tertiary hospitals. The results of 
our survey showed poor state of AMS practice 
among tertiary hospitals in Nigeria. Both the 
core and supplementary strategies were either 
non-existent or poorly practiced. The poor state 
of AMS practice is evidenced by the few AMS 
committees and near-total lack of leadership 
support and resource allocation. The health 
system has not identified AMS as a priority, 
hence the absence of policy and lack of resource 
allocation. This level of practice could explain 
the high level of antimicrobial use earlier 
reported in some Nigerian hospitals (23-26).  
 The few hospitals with AMS committees 
do not have any terms of reference and do not 
hold regular meetings. This could also partly 
explain the absence of leadership commitment 
or the reason for it. It will be challenging to 
operate a successful and sustainable AMS prog- 
ramme without leadership support and a func- 
tional AMS committee to drive the process. The 
near absence of AMS actions or interventions 
such as education and training, monitoring and 
evaluation, reporting and feedback might all be 
due to the absence of functional AMS com- 
mittees, and leadership/administration support. 
 Although the six hospitals with AMS 
committees had multidisciplinary members with 
clear leadership, this has not engendered the 
implementation of the supplementary strategies 
such as education and training, which calls to 
question the level of knowledge about AMS of 
the membership of these committees. An inter- 
esting aspect of the situation in these hospitals 
is the availability of adequate facilities for 
culture and sensitivity. Paradoxically, a previous 
study in Nigeria had identified poor use of the 
clinical microbiology laboratory by physicians 
(27). Some of the reasons advanced for the 
finding in this previous study included the belief 
by many physicians that “clinical diagnosis was 
sufficient”, frustration at the “delay in getting 
results”, physician having sufficient “knowledge 
of potent antibiotics”, lack of access to clinical 
laboratory facilities, and non-availability of path- 
ologists to assure the quality of laboratory tests. 
Under this scenario, a substantial number of 
prescriptions are bound to be or remain empiric 
and inappropriate, a situation that fuels anti- 
microbial resistance. In the absence of any 
significant AMS activity, there was nothing to 
monitor or evaluate. The participation in the 
global point prevalent survey was only a starting 
point for monitoring and evaluation activity. 
 The close relationship between AMS and 
IPC is well established (22,28,29). Despite the 
availability of IPC committee in five hospitals, 
AMS-IPC interaction holds only in one hospital, 
suggesting lack of appreciation of the need for 
this. The absence of AMS committee in some of 
the hospitals could also have accounted for the 
absence of this valuable handshake. Alongside 
the huge AMS deficits highlighted here, there 
are also some notable challenges to implemen- 
tation of AMS in the hospitals. These include but 
not limited to lack of funding, poor awareness of 
AMS usefulness by staff, prescribers’ opposition, 
and lack of leadership support. Similar findings 
have been reported in a previous study of eleven 
hospitals in six continents (30,31), where it was 
shown that, amongst others, the administra- 
tions in some of the study sites were not aware 




of the programme. It would therefore be difficult 
for the leadership to support a programme it 
was never aware of. This emphasizes the need 
for adequate and proper communication to 
ensure that all relevant interest groups and 
stakeholders are involved for a functional and 
sustainable AMS programme.  
Conclusion: 
 In conclusion, AMS, a proven strategy in 
curbing AMR, is established in only few tertiary 
health facilities in Nigeria. This survey identified 
gaps and factors impeding the implementation 
of this strategy to include lack of education, 
training, and proper communication. If these 
gaps are addressed, it will aid the implemen- 
tation and sustenance of AMS in these hospitals 
through appropriate measures that deal with 
issues of leadership support, lack of funding, 
prescribers’ opposition, and low awareness of 
AMS usefulness by staff. The challenges of poor 
knowledge, implementation strategies, monito- 
ring, reporting and feedback will also be largely 
addressed. 
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